PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-May-2022  Accelerated Biosciences and Pluristyx Announce Availability of Human Trophoblast Stem Cell (hTSC) Derived iPSCs Businesswire
04-May-2022 Amneal Reports First Quarter 2022 Financial Results Businesswire
04-May-2022 LivaNova Reports First-Quarter 2022 Results Businesswire
04-May-2022 Vizient and RISCS Announce Pilot Program to Improve Pharmaceutical Supply Chain Resilience Businesswire
04-May-2022 United Therapeutics Corporation Reports First Quarter 2022 Financial Results Businesswire
04-May-2022 LinKinVax Appoints Dr. Jiong Ma as Independent Board Member Businesswire
04-May-2022 BeiGene Announces the Approval in China of BLINCYTO® (Blinatumomab) for Injection for Pediatric Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (ALL) Businesswire
04-May-2022 Insights on the Healthcare BPO Global Market to 2027 - by Payer Service, Provider Service, Pharmaceutical Service and Region - ResearchAndMarkets.com Businesswire
04-May-2022 North America Stacker Crane Markets Report 2021-2022 & 2027 - ResearchAndMarkets.com Businesswire
04-May-2022 Women's Health and Beauty Supplements Market Forecast Report 2022: Focus on Ingredients, Application and Distribution Channel - ResearchAndMarkets.com Businesswire
04-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
04-May-2022 Innate Pharma Establishes an At-The-Market (“ATM”) Program on Nasdaq Businesswire
03-May-2022 SQZ Biotechnologies to Present at Upcoming Investor Conferences Businesswire
03-May-2022 AdaptHealth to Participate in BofA Securities 2022 Healthcare Conference Businesswire
03-May-2022 ICON plc to present at the BofA Securities 2022 Healthcare Conference Businesswire
03-May-2022 Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results Businesswire
03-May-2022 Aura Biosciences Presents Preclinical Data Highlighting AU-011’s Anti-Tumor Activity in Choroidal Metastasis, an Additional Ocular Oncology Indication at the 2022 ARVO Annual Meeting Businesswire
03-May-2022 Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis Businesswire
03-May-2022 MedinCell’s partner Teva provides additional information regarding the New Drug Application for mdc-IRM Businesswire
03-May-2022 North America Insect Protein Markets Size, Shares, Industry Trends, & Analysis Report 2021-2022 & 2027 - ResearchAndMarkets.com Businesswire